- Home
- APRE vs COSM Comparison
APRE vs COSM Comparison
Compare APRE & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- COSM
- Stock Information
- Founded
- APRE 2006
- COSM 2009
- Country
- APRE United States
- COSM United States
- Employees
- APRE N/A
- COSM 123
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- COSM Other Pharmaceuticals
- Sector
- APRE Health Care
- COSM Health Care
- Exchange
- APRE Nasdaq
- COSM Nasdaq
- Market Cap
- APRE 15.8M
- COSM 13.6M
- IPO Year
- APRE 2019
- COSM 2013
- Fundamental
- Price
- APRE $3.05
- COSM $0.58
- Analyst Decision
- APRE Strong Buy
- COSM
- Analyst Count
- APRE 2
- COSM 0
- Target Price
- APRE $15.50
- COSM N/A
- AVG Volume (30 Days)
- APRE 22.6K
- COSM 132.5K
- Earning Date
- APRE 11-07-2024
- COSM 11-14-2024
- Dividend Yield
- APRE N/A
- COSM N/A
- EPS Growth
- APRE N/A
- COSM N/A
- EPS
- APRE N/A
- COSM N/A
- Revenue
- APRE $1,310,839.00
- COSM $56,042,109.00
- Revenue This Year
- APRE $134.21
- COSM $4.53
- Revenue Next Year
- APRE N/A
- COSM $25.00
- P/E Ratio
- APRE N/A
- COSM N/A
- Revenue Growth
- APRE 130.31
- COSM 13.01
- 52 Week Low
- APRE $2.15
- COSM $0.47
- 52 Week High
- APRE $8.85
- COSM $1.65
- Technical
- Relative Strength Index (RSI)
- APRE 43.20
- COSM 27.63
- Support Level
- APRE $3.02
- COSM $0.69
- Resistance Level
- APRE $3.39
- COSM $0.73
- Average True Range (ATR)
- APRE 0.30
- COSM 0.06
- MACD
- APRE -0.01
- COSM -0.02
- Stochastic Oscillator
- APRE 3.85
- COSM 0.00
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.